Log In / Join Now

Magazine Archives: Jan. 31 - Feb. 28, 2011

Resveratrol: Not a Silver Bullet?

Issue: February 28, 2011


GlaxoSmithKline has halted the development of SRT501, an experimental drug based on resveratrol, but that doesn't mean the pharmaceutical firm has stopped developing any medicines based on the compound. Wine Spectator assistant editor Stephanie Cain explains.


For the full article, check out the new issue of Wine Spectator, on newsstands February 1, 2011.


To continue reading this page, become a WineSpectator.com member today!

Do you have a Wine Spectator magazine subscription? Save 50% on your Online Membership right now!


Already a member?


Job Opportunity

WineSpectator.com seeks an assistant editor in its New York City office to help develop content for its website, e-mail newsletters, social media platforms and apps. Candidates should have one to three years of journalism experience in a digital environment and be able to handle daily deadlines. Get more details.


WineRatings+ app: Download now for 300,000+ ratings.